Literature DB >> 26660539

Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption.

Veedamali S Subramanian1, Nils Lambrecht2, Christian Lytle3, Hamid M Said4.   

Abstract

Riboflavin (RF) is indispensable for normal cell metabolism, proliferation, and growth. The RFVT-3 protein (product of the Slc52a3 gene) is expressed in the gut with the expression being restricted to the apical membrane domain of the polarized intestinal epithelial cells. The relative contribution of RFVT-3 to total carrier-mediated RF uptake in the native intestine, however, is not clear. We addressed this issue in the current investigation using a conditional (intestinal-specific) RFVT-3 knockout (cKO) mouse model developed by the Cre/Lox approach. All RFVT-3 cKO mice were found to be RF deficient and showed a significant growth and development retardation; also, nearly two-thirds of them died prematurely between the age of 6 and 12 wk. In vivo (intestinal and colonic loops) and in vitro (native isolated intestinal epithelial cells) uptake studies showed a severe inhibition in carrier-mediated RF uptake in the cKO mice compared with control littermates. We also observed a significant increase in the level of expression of oxidative stress-responsive genes in the intestine of the cKO mice compared with control littermates. Supplementation of the RFVT-3 cKO mice with pharmacological doses of RF led to a complete correction of the growth retardation and to normalization in the level of expression of the oxidative stress-responsive genes in the gut. These results show, for the first time, that the RFVT-3 system is the main transporter involved in carrier-mediated RF uptake in the native mouse small and large intestine, and that its dysfunction impairs normal RF body homeostasis.

Entities:  

Keywords:  intestine

Mesh:

Substances:

Year:  2015        PMID: 26660539      PMCID: PMC4754740          DOI: 10.1152/ajpgi.00340.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Riboflavin (vitamin B-2) reduces hepatocellular injury following liver ischaemia and reperfusion in mice.

Authors:  Sheila Cristina Sanches; Leandra Naira Z Ramalho; Mariana Mendes-Braz; Vânia Aparecida Terra; Rubens Cecchini; Marlei Josiele Augusto; Fernando Silva Ramalho
Journal:  Food Chem Toxicol       Date:  2014-02-18       Impact factor: 6.023

3.  Vitamins and alcoholism. Introduction.

Authors:  C M Leevy; H Baker
Journal:  Am J Clin Nutr       Date:  1968-11       Impact factor: 7.045

4.  Protection by vitamin B2 against oxidant-mediated acute lung injury.

Authors:  A Seekamp; D E Hultquist; G O Till
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

5.  Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding.

Authors:  J Pangrekar; K Krishnaswamy; V Jagadeesan
Journal:  Food Chem Toxicol       Date:  1993-10       Impact factor: 6.023

6.  Multiple vitamin status in Crohn's disease. Correlation with disease activity.

Authors:  F Kuroki; M Iida; M Tominaga; T Matsumoto; K Hirakawa; S Sugiyama; M Fujishima
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Riboflavin depletion of intestinal cells in vitro leads to impaired energy generation and enhanced oxidative stress.

Authors:  Eun-Sook Lee; Bernard M Corfe; Hilary J Powers
Journal:  Eur J Nutr       Date:  2012-11-06       Impact factor: 5.614

8.  Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation.

Authors:  Koichiro Iwanaga; Tomomi Hasegawa; Donald E Hultquist; Hiroaki Harada; Yasushi Yoshikawa; Sunitha Yanamadala; Hui Liao; Scott H Visovatti; David J Pinsky
Journal:  Transplantation       Date:  2007-03-27       Impact factor: 4.939

9.  Uptake of riboflavin by intestinal basolateral membrane vesicles: a specialized carrier-mediated process.

Authors:  H M Said; D Hollander; R Mohammadkhani
Journal:  Biochim Biophys Acta       Date:  1993-06-05

10.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.

Authors:  Peter Green; Matthew Wiseman; Yanick J Crow; Henry Houlden; Shelley Riphagen; Jean-Pierre Lin; F Lucy Raymond; Anne-Marie Childs; Eamonn Sheridan; Sian Edwards; Dragana J Josifova
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

View more
  12 in total

1.  Structure/functional aspects of the human riboflavin transporter-3 (SLC52A3): role of the predicted glycosylation and substrate-interacting sites.

Authors:  Veedamali S Subramanian; Subrata Sabui; Trevor Teafatiller; Jennifer A Bohl; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-21       Impact factor: 4.249

Review 2.  Riboflavin transport and metabolism in humans.

Authors:  Maria Barile; Teresa Anna Giancaspero; Piero Leone; Michele Galluccio; Cesare Indiveri
Journal:  J Inherit Metab Dis       Date:  2016-06-06       Impact factor: 4.982

3.  Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3.

Authors:  Ram Lakhan; Veedamali S Subramanian; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-09-14       Impact factor: 4.052

4.  SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.

Authors:  Tamilarasan Udhayabanu; Veedamali S Subramanian; Trevor Teafatiller; Vykuntaraju K Gowda; Varun S Raghavan; Perumal Varalakshmi; Hamid M Said; Balasubramaniem Ashokkumar
Journal:  Clin Chim Acta       Date:  2016-10-01       Impact factor: 3.786

5.  Effect of the proinflammatory cytokine TNF-α on intestinal riboflavin uptake: inhibition mediated via transcriptional mechanism(s).

Authors:  Kasin Yadunandam Anandam; Omar A Alwan; Veedamali S Subramanian; Padmanabhan Srinivasan; Rubina Kapadia; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2018-08-29       Impact factor: 4.249

6.  Sodium Butyrate Enhances Intestinal Riboflavin Uptake via Induction of Expression of Riboflavin Transporter-3 (RFVT3).

Authors:  Veedamali S Subramanian; Subrata Sabui; Christopher W Heskett; Hamid M Said
Journal:  Dig Dis Sci       Date:  2018-10-01       Impact factor: 3.199

7.  Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-κB-mediated pathway.

Authors:  Ganapathy A Subramenium; Subrata Sabui; Jonathan S Marchant; Hamid M Said; Veedamali S Subramanian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-04       Impact factor: 4.052

8.  Tumor necrosis factor alpha reduces intestinal vitamin C uptake: a role for NF-κB-mediated signaling.

Authors:  Veedamali S Subramanian; Subrata Sabui; Ganapathy A Subramenium; Jonathan S Marchant; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-06       Impact factor: 4.052

9.  Identification of transmembrane protein 237 as a novel interactor with the intestinal riboflavin transporter-3 (RFVT-3): role in functionality and cell biology.

Authors:  Subrata Sabui; Veedamali S Subramanian; Quang Pham; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2019-03-20       Impact factor: 5.282

Review 10.  Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy.

Authors:  Maria Tolomeo; Alessia Nisco; Piero Leone; Maria Barile
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.